期刊文献+

肺癌术中血癌胚抗原mRNA的检测及意义 被引量:3

Detection of blood dissemination during the operation of lung cancer and its significance
原文传递
导出
摘要 目的探讨肺癌术中有无肿瘤细胞的血行播散及其规律。方法对52例肺癌、5例肺部良性病变手术患者,于开胸时、结扎肺静脉时及结扎后1h取外周静脉血,结扎肺静脉时取肺静脉血,采用巢式逆转录聚合酶链反应(RTPCR)技术检测血中癌胚抗原(CEA)mRNA的表达量(以经内参照校正的紫外灯光下灰度值表示)。取人腺癌细胞系A549作阳性对照并检测该方法的灵敏度。结果CEAmRNA检测阳性率开胸时为31%(16/52),结扎肺静脉时外周血与肺静脉血、结扎肺静脉后1h外周静脉血均为54%(28/52),且病例一致。开胸时的CEAmRNA表达水平最低95±20,结扎肺静脉时肺静脉血最高126±22,结扎肺静脉时外周静脉血与结扎肺静脉后1h的外周静脉间差异无统计学意义(P>0.05)。CEAmRNA的术中阳性率,鳞癌患者为64%(14/22),腺癌患者为47%(14/30),阳性率与肿瘤性质无关(χ2=1.47,P>0.05);中央型肺癌的术中阳性率(80%,20/25)显著高于周围型肺癌(30%,8/27)(χ2=16.81,P=0.000);TNM分期Ⅰ、Ⅱ、Ⅲ、Ⅳ期者阳性率分别为32%(8/25),55%(6/11),93%(14/15)和0(0/1),分期较晚者显著高于分期较早者(χ2=17.93,P=0.000)。5例阴性对照均为阴性。经检验该方法的灵敏度为1×10-6。结论肺癌术中的确存在血行播散,结扎肺静脉的早晚可能对瘤细胞播散量有较大影响; Objective To evaluate the possibility of dissemination of lung cancer cells through blood during the operation for lung cancer. Methods The blood samples were taken from 52 patients with non-small cell lung cancer(NSCLC) and 5 patients with benign lung diseases at four different intervals during the operation. The transcription of carcinoembryonic antigen(CEA) messenger ribonucleic acid was assayed by means of nested reverse transcriptase polymerase chain reaction (RT-PCR). A549 ( a human adenocarcinoma cell line ) served as positive control. The sensitivity has been tested using quantificationally diluted A549 cells. Results The CEA mRNA positive rates of all four time spots are as follows: 31%(16/52) at beginning of the operation (sample taken from peripheral vein), 54%(28/52) at ligating the pulmonary vein (peripheral vein), 54%(28/52) at ligating the pulmonary vein (pulmonary vein) and 54%(28/52) at 1 hour after ligating the pulmonary vein (peripheral vein ). There is no relationship between the tumor identity and the positive rate of CEA mRNA. The positive rate of CEA mRNA is higher in patients with centrally located lung cancer than that in patients with peripherally located lung cancer, similar phenomenon is also found between patients with advanced lung cancer and the patients with early stage of lung cancer. No negative control samples was found to be positive for CEA mRNA, the sensitivity of our test was 1×10^-6 . Conclusions The cancer cell dissemination during operation was demonstrated indirectly in our study, the time of pulmonary vein ligation (later or earlier) may affect the quantity of tumor cells released into circulation. Patients with lung cancer of central type and late TNM stage have more possibility of cancer cell dissemination during operation. More effective means may be needed to avoid the dissemination of cancer cells.
出处 《中华外科杂志》 CAS CSCD 北大核心 2005年第2期76-79,共4页 Chinese Journal of Surgery
关键词 结扎 术中 肺静脉 肺癌 阳性率 开胸 外周静脉血 RNA 表达量 RT—PCR Lung neoplasms Neoplasm metastasis Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献12

  • 1曹卡加,崔念基,刘亦龙,潘国英.鼻咽癌颈淋巴结活检对远处转移的影响[J].癌症,1999,18(5):588-589. 被引量:20
  • 2黄进肃,董强刚,周允中,廖美琳,包国良.围手术期血循环中肺癌细胞与预后的关系[J].肿瘤学杂志,2002,8(1):31-34. 被引量:3
  • 3Kurusu Y, Yamashita J, Hayashi N,et al.The sequence of vessel ligation affects tumour release into the circulation. J Thorac Cardiovasc Surg,1998, 116:107-113.
  • 4Steinert R, Lippert H, Reymond MA. Tumor cell dissemination during laparoscopy: prevention and therapeutic opportunities. Dig Surg, 2002,19:464-472.
  • 5Kihara M, Yokomise H, Irie A,et al. Malignant adeno-myoepithelioma of the breast with lung metastases: report of a case. Surg Today, 2001,31:899-903.
  • 6Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology,1994,20:1418-1425.
  • 7Manhani AR, Manhani R, Soares HP, et al.CK-19 exression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy. Breast Cancer Res Treat,2001,66:249-254.
  • 8Shingyoji M, Takiguchi Y, Watanabe R, et al. Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinoma. Cancer ,2003, 97:1057-1062.
  • 9Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res, 1995, 55: 3417-3420.
  • 10Yamashita JI, Kurusu Y, Fujino N, et al. Detection of circulating tumor cells in patients with non-small cell ung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg, 2000 ,119:899-905.

二级参考文献10

共引文献21

同被引文献24

  • 1汪洋,邹丽娟,许冠东,宫琳琳,周小棉,邵淑娟.微流控芯片检测肺癌患者血浆中p16基因异常甲基化在临床应用的评价[J].生物化学与生物物理进展,2004,31(12):1085-1090. 被引量:7
  • 2Hippo Y,Watanabe K,Watanabe A,et al.Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.Cancer Res,2004,64:2418-2423.
  • 3Mast AE,Higuchi DA,Huang ZF,et al.Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.Biochem J,1997,327:577-583.
  • 4Sung YK,Hwang SY,Farooq M,et al.Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.Exp Mol Med,2003,35:257-262.
  • 5Wichert A,Stege A,Midorikawa Y,et al.Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells.Oncogene,2004,23:945-955.
  • 6Farooq M,Hwang SY,Park MK,et al.Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest.Mol Cells,2003,15:356-360.
  • 7Huang JS,Chao CC,Su TL,et al.Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma.Biochem Biophys Res Commun,2004,315:950-958.
  • 8Fehr JE,Trotter GW,Oxford JT,et al.Comparison of Northern blot hybridization and a reverse transcriptase-polymerase chain reaction technique for measurement of mRNA expression of metalloproteinases and matrix components in articular cartilage and synovial membrane from horses with osteoarthritis.Am J Vet Res,2000,61:900-905.
  • 9Hsu HC,Cheng W,Lai PL.Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma:biological significance and temporospatial distribution.Cancer Res,1997,57:5179-5184.
  • 10Zhu ZW,Friess H,Wang L,et al.Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.Gut,2001,48:558-564.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部